Clinical Trials Directory

Trials / Completed

CompletedNCT00571974

Treatment of Oral Premalignant Lesions With 5-ALA PDT

A Combined Phase I/II Single Site Study to Determine the Safety and Efficacy of Photodynamic Therapy (PDT) Utilizing 5-aminolevulinic Acid (5-ALA) and PDT in the Treatment of Premalignant Oral and/or Oropharynx Lesions.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
29 (actual)
Sponsor
University of Arkansas · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Oral leukoplakia within the mouth is a visible white patch which can develop into cancer if not treated. There is no good treatment for these lesions, apart from surgery which is associated with significant side effects and physical deformation of the treated area. The investigators hypothesized that photodynamic therapy can be used safely and effectively to induce significant regression of oral leukoplakia.

Detailed description

This is a combined Phase I/II non-randomized prospective study designed to determine the safety and assess the clinical efficacy of PDT in the treatment of oral leukeplekia with 5-ALA and 585-nm PDL with 1.5 ms pulse time. In the first part of the study we determined the maximum tolerated dose (MTD) of the PDL radiant exposure in combination with 5-ALA. In the second phase of the study, this dose is used to treat subjects at the MTD in order to determine the efficacy of the treatment by documenting the regression of the treated lesions.

Conditions

Interventions

TypeNameDescription
DEVICEPDL-585, ScleroPLUS laserPDT Treatment; emits light with 585 nm wavelength in pulses of 1.5 milliseconds in sections of 5 mm diameter to target the lesion and surrounding tissue
DRUG5-Aminolevulinic Acid (Levulan KerastickTM)Topically administered; incubation time 60-180 minutes; single dose (345 mg of active 5-ALA in 1.5 ml solution); soaked onto white gauze and applied to lesion, covered with sterile Xeroform gauze
PROCEDUREFluorescence Diagnosis ImagingFD Image taken prior to PDL-585 usage

Timeline

Start date
2007-01-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2007-12-12
Last updated
2015-03-24
Results posted
2012-11-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00571974. Inclusion in this directory is not an endorsement.